community download

Download presentation from Debra Miller, CureDuchenne

Debra Miller, CureDuchenne, CEO and Founder joined us at the World Orphan Drug Congress Europe 2015 to provide key insight into how Venture Philanthropy Can Effectively Fund Orphan Drug Development. CureDuchenne is the leading Duchenne organization that raises awareness and funds research to find a cure for Duchenne muscular dystrophy, a fatal genetic disease that causes muscle degeneration that impacts 1 in 3,500 boys. CureDuchenne has an extremely successful track record of translating science into late stage clinical trials.

Download this presentation now to see How Venture Philanthropy Can Effectively Fund Orphan Drug Development. Get your copy now and discover more about:

  • CureDuchenne Success -Snapshot
  • Venture Philanthropy Defined
  • Venture Philanthropy vs. Traditional Fundraisingt
  • What Does Investing in an Orphan Drug Entail?
  • What do Nonprofits Bring to the Table?
  • How to Reviewing the Terms of Your Involvement and Draw up Appropriate Agreements
  • Outcomes of Drug Failure vs. Drug Success

Get your copy here >

 

Some quick details

Email Address:*
First name:*
Last name:*
Job Title:*
Company:*
Industry:
Country:*

Remember my details Information

Information
Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details


Privacy statement »
Manage your email preferences »
 

You will be emailed the document as an attachment (1,569Kb in size)